Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli. - sprookjes - yvandenbroek - TriplyDB

Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli.

Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli.

http://www.wikidata.org/entity/Q40666822

about

"One-size-fits-all"? Optimizing treatment duration for bacterial infections Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient.Emergence and spread of antibiotic resistance: setting a parameter space.Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection Optimizing drug exposure to minimize selection of antibiotic resistance.The use and risks of antibiotics in critically ill patients.Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma.In vitro pharmacokinetic and pharmacodynamic evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae.Resistance through a different prism.Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain.

P2860

Q28478851-D3412364-53BE-4F03-B5EC-BC39521706A6 Q30393531-6EBC7649-C40C-4CFC-81A7-C8591C4CF6D3 Q30519515-BCA5D5B6-4133-4287-9836-84F22A49BEB8 Q33667581-F7665F2C-3060-4B3C-ADDC-365024AAEBAD Q33767602-654D7E53-1CCA-408C-8F0C-913ADEC68A66 Q35130454-F6474EA6-2CA6-4032-88F1-BB176A6CB43F Q35986250-5E1186B1-2881-416F-B68E-2E21704E0FB4 Q36095024-92349ACB-0E38-4410-814C-F2D14D433AE1 Q36903693-CB20886C-F582-412A-83B5-A70DD4C8108E Q38767901-13FAC528-92F9-4C2A-A9C2-05783D95320E Q40779607-5B0D0D44-6B63-4517-AB39-5254CD4FE559 Q42111255-8C643C9C-D494-4A42-A386-A343F5D9BC2D Q46956797-B3CCB3FB-77B1-4D6C-B694-727746EAD8E4 Q54357412-3D41D23F-51E3-4712-914E-95C2E2254AAF

P2860

Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli.

http://www.wikidata.org/entity/Q40666822

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Pharmacodynamic model to descr ...... me-resistant Escherichia coli.

@en

type

label

Pharmacodynamic model to descr ...... me-resistant Escherichia coli.

@en

prefLabel

Pharmacodynamic model to descr ...... me-resistant Escherichia coli.

@en

P1433

Q40666822-C287326E-4B65-489A-8887-3A5D29332CEC

P1476

Q40666822-D5D05DB4-CB99-473B-9584-1FBEB08A171B

P2093

Q40666822-4CDD94B0-7A1C-4815-86C6-827970D66F22

Q40666822-6D806112-B063-4412-AADB-321B1D3DB1ED

Q40666822-93D782F3-09DB-454B-90C9-6F7725A364B7

Q40666822-A225DFAB-4E2B-4DD0-82BA-1FB101371F94

P2860

Q40666822-0CD2D5F7-9EBA-4F02-A92A-11CA852D636B

Q40666822-0CEE6349-AFF3-41C9-A756-C808DE777677

Q40666822-13DED568-615B-43B4-8D73-A419BF028EA8

Q40666822-31F2997A-E607-478F-927E-B24FF2711A82

Q40666822-34717112-ADA1-4335-B17A-9974F8113394

Q40666822-35C3C327-D64D-41E6-AD74-2A93610BB8AF

Q40666822-37172E27-BFE6-4E5A-B598-293E64A81B32

Q40666822-3DFCE54A-8ADE-4128-B1CB-9453C486847F

Q40666822-4C37B75F-9046-4AAB-8248-C94B56B1C9E2

Q40666822-4F19E5EF-D276-4CD2-8DE2-653BA00B59AD

P304

Q40666822-D08D6951-B1B9-4480-B369-6FC5E0306880

P31

Q40666822-58B73EA6-64CD-4A2F-B5E5-F297D0C94D26

P356

Q40666822-ED05D779-F367-440E-8C59-E64768B12274

P407

Q40666822-B8118490-D8F3-4E7A-A7F3-5BBDD4DB16F0

P433

Q40666822-11D54566-714A-4943-972E-B1F0C91709AE

P478

Q40666822-8343A1FE-632C-44B0-9EF3-91806150FCBF

P577

Q40666822-231BEF6F-4D42-4F9B-AE7A-8371F10CB1E1

P5875

Q40666822-AF9636B1-BD63-4C0E-8AE1-3FFC499CF24F

P698

Q40666822-AF8A2F51-0B09-4132-ADBF-625278B54248

P932

Q40666822-1C46B394-DF80-495B-9C5A-88AD252EFF16

P356

AAC.49.12.5081-5091.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacodynamic model to descr ...... me-resistant Escherichia coli.

@en

P2093

Dan I Andersson

http://www.w3.org/2001/XMLSchema#string

Otto Cars

http://www.w3.org/2001/XMLSchema#string

Patricia Geli

http://www.w3.org/2001/XMLSchema#string

Sara K Olofsson

http://www.w3.org/2001/XMLSchema#string

P2860

A functional classification scheme for beta-lactamases and its correlation with molecular structure

The epidemiology of beta-lactamases.

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.

Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae

Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection

Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model

Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection

In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

P304

5081-5091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.12.5081-5091.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7464975

http://www.w3.org/2001/XMLSchema#string

P698

16304176

http://www.w3.org/2001/XMLSchema#string

P932

1315921

http://www.w3.org/2001/XMLSchema#string